Mechanism of action of the sesquiterpene compound helenalin in rhabdomyosarcoma cells
Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in paediatric patients. Relapsed or refractory RMS shows very low 5-year survival rates, which urgently necessitates new chemotherapy agents. Herein, the sesquiterpene lactone, helenalin, was investigated as a new potential therapeutic...
主要な著者: | Mun, H, Townley, HE |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
MDPI
2021
|
類似資料
-
Mechanism of Action of the Sesquiterpene Compound Helenalin in Rhabdomyosarcoma Cells
著者:: Hakmin Mun, 等
出版事項: (2021-12-01) -
CD44 and CD221 directed magnetic cubosomes for the targeted delivery of helenalin to rhabdomyosarcoma cells
著者:: Mun, H, 等
出版事項: (2022) -
Active targeting of rhabdomyosarcoma cells using helenalin-loaded functionalised cubosomes
著者:: Mun, HM
出版事項: (2023) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
著者:: Feng, XiaoLing, 等
出版事項: (2013) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
著者:: Lim Chuan, 等
出版事項: (2012-07-01)